title: Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione.
authors.forename: M
authors.initials: M
authors.lastname: Emoto
authors.forename: N
authors.initials: N
authors.lastname: Fukuda
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamori
authors.forename: A
authors.initials: A
authors.lastname: Taguchi
authors.forename: S
authors.initials: S
authors.lastname: Okuya
authors.forename: Y
authors.initials: Y
authors.lastname: Oka
authors.forename: Y
authors.initials: Y
authors.lastname: Tanizawa
mesh_terms: D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004487:Edema / Q000097:blood* / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
chemical_list: D045162:Thiazolidinediones; D042461:Vascular Endothelial Growth Factor A; C089946:2,4-thiazolidinedione